Facing rival drugs, Novartis gets win with Afinitor in Europe
- 02-Jun-2016
LONDON: Efforts by Novartis to defend its blockbuster cancer drug Afinitor against competitors got a boost on Thursday from European regulators, who approved it for use on certain types of advanced gastrointestinal and lung neuroendocrine tumors.
Europe lifts warning on Pfizer smoking cessation drug
- 23-May-2016
LONDON: European regulators have lifted a warning on Pfizer's smoking cessation drug Champix - called Chantix in the United States - after a clinical study concluded it did not appear to increase the risk of neuropsychiatric side effects.